Current Research in Drug Discovery
ISSN 2333-3235 (print)eISSN 2333-3243 (online) Open access
Editorial board
33 editors in 14 countries: the Editor-in-Chief, 4 associate editors and 28 board members.
Editor-in-Chief · 1
Haifeng Frank JiDrexel UniversityUnited States
Associate editors · 4
Farid A BadriaMansoura UniversityEgypt
Gagan DhawanAcharya Narendra Dev College, University of DelhiIndia
Hongtao LuVice President & Chief Scientific Officer, Zai Laboratory Inc.China
Jan EickhoffDortmund GmbH, Head of Assay Development and Screening, Hit Discovery Constance GmbH, Managing DirectorGermany
Editorial board members · 28
Andy ZayengaManaging Director, SmarterLab - Laboratory Automation ConsultingUnited States
David TattersallDirector Parkinson’s Disease Group Neurodegeneration DPU, GlaxoSmithKline.United Kingdom
Davide GianniTeam LeaderInnovative Medicines and Early DevelopmentDiscovery Sciences - Cellular Assay DevelopmentAstrazenecaUnited Kingdom
Fatemeh MirzaeiHamadan University of Medical SciencesIran
Gael HédouNeurosciences Centre of Excellence for Drug DiscoveryUnited Kingdom
Gaurav DasChittaranjan National Cancer InstituteIndia
Jad AbdallahLebanese American UniversityLebanon
Jonathan WingfieldUniversity of WalesUnited Kingdom
Leonardo J. SolmeskyWeizmann Institute of ScienceIsrael
Masamitsu KanadaMichigan State UniversityUnited States
Matt BoeckelerAutomation & Research Technologies Team Chair, AstraZenecaUnited States
Narendra PamidiSchool of Medicine, Monash University MalaysiaMalaysia
Paul AndrewsStem Cell Solutions LtdScotland
Pratima SrivastavaAssociate Director Biology, GVK BiosciencesIndia
Qiyue HuAssociate Director, Shanghai Hengrui Pharmaceutical Co.China
Rathnam ChaguturuFounder and CEO, iDDPartnersUnited States
Rusliza BasirUniversiti Putra MalaysiaMalaysia
Sanjeev SaxenaSenior Research Scientist, Orchid Chemicals & Pharmaceuticals LtdIndia
Tiziana AdageBIT Pharma GmbHAustria
Tülay BakirelIstanbul UniversityTurkey